Inflammatory Bowel Disease Drugs Market Growth: Market Outlook and Forecast
Inflammatory
Bowel Disease Drugs Market size was valued at USD 20.55 Billion in 2022 and
is expected to reach USD 26.85 Billion By 2030 and grow at a CAGR of 3.4% over
the forecast period of 2023-2030.
The Inflammatory Bowel Disease (IBD) Drugs Market is
witnessing significant growth due to the rising prevalence of inflammatory
bowel diseases such as Crohn's disease and ulcerative colitis. These chronic conditions
affect the digestive tract, leading to inflammation, pain, and other
debilitating symptoms.
The market for IBD drugs is driven by several factors.
Firstly, the increasing awareness about these diseases among patients and
healthcare professionals has led to early diagnosis and treatment initiation.
This has resulted in a higher demand for effective medications that can manage
symptoms and improve patients' quality of life.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2988
Additionally, advancements in medical research have led to
the development of innovative drugs with improved efficacy and safety profiles.
Biologic therapies, such as anti-TNF agents and integrin inhibitors, have
revolutionized the treatment landscape for IBD. These drugs target specific
molecules involved in the inflammatory process, providing better control over
disease progression.
KEY MARKET SEGMENTS
By Type
·
Ulcerative Colitis
·
Crohn’s Disease
By Drug Class
·
TNF inhibitors
·
Corticosteroids
·
Aminosalicylates
·
JAK inhibitors
·
Anti-integrin
·
IL inhibitors
By Distribution Channel
·
Hospital Pharmacy
·
Drug Store
·
Retail Pharmacy
·
Online Pharmacy
Major Players Listed in the Report are as Follows:
AbbVie
Inc, Biogen, Takeda Pharmaceutical Company Limited, Novartis AG, Pfizer Inc,
Lilly, UCB S.A., Johnson & Johnson Services, Inc., CELLTRION INC
Bristol-Myers Squibb Company and others the final reports list additional
participants.
Other
Report
Transplantation
Market Analysis
About US:
SNS Insider has been a leader in data and analytics globally
with its authentic consumer and market insights. The trust of our clients and
business partners has always been at the center of who we are as a company. We
are a business that leads the industry in innovation, and to support the
success of our clients, our highly skilled engineers, consultants, and data
scientists have consistently pushed the limits of the industry with innovative
methodology and measuring technologies.
We assist our clients to anticipate industrial, economic,
and consumer trends to drive disruptive change by fusing global experience with
local information from experts throughout the world. We bring context to
strategic and tactical data by bridging approaches based on data science and
field research, assisting you in addressing your most pressing problems and
spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Comments
Post a Comment